Browse 2623 Federal Food and Nutrition Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Food and Nutrition grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
Close Date | Grant Title | Agency |
May 20th, 2024 |
Development and Maintenance of the Animal Food Regulatory Program Standards (U19) Clinical Trial Not Allowed |
Food and Drug Administration |
January 7th, 2027 |
Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed) |
National Institutes of Health |
January 7th, 2027 |
Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed) |
National Institutes of Health |
May 20th, 2024 |
Use of Digital Health Technologies in Clinical Investigations to Support Drug and Biological Product Development (U01) Clinical Trials Optional |
Food and Drug Administration |
December 9th, 2026 |
Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional) |
National Institutes of Health |
April 29th, 2024 |
PDS Annual Program Statement 2024 |
US Mission to France |
January 7th, 2027 |
NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) |
National Institutes of Health |
May 10th, 2024 |
Cooperative Agreement to Support the World Trade Organization's (WTO) Standards and Trade Development Facility (STDF) (U01) Clinical Trials Not Allowed |
Food and Drug Administration |
May 6th, 2024 |
Alliance to Support the Activities of the Integrated Food Safety System (IFSS), including the Grade A Milk Safety and National Shellfish Sanitation Programs (U01) Clinical Trials Not Allowed |
Food and Drug Administration |
January 7th, 2026 |
Elucidating Mechanisms Associated with HIV Related Co-Morbidities in Populations Experiencing Health Disparities (R01 - Clinical Trials Not Allowed) |
National Institutes of Health |
January 7th, 2025 |
Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional) |
National Institutes of Health |
July 30th, 2024 |
Impact of Comorbidities and Co-Infections on HIV Reservoirs (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
May 13th, 2024 |
Cooperative Agreement for Long Term Data Collection on Antimicrobial Use in Animals (U01) Clinical Trial Not Allowed |
Food and Drug Administration |
May 13th, 2025 |
Drug Development Tools Research Grants (U01) Clinical Trials Optional |
Food and Drug Administration |
April 1st, 2024 |
Advancing Conformance with the Voluntary National Retail Food Regulatory Program Standards (VNRFRPS) by State, Local, Tribal, and Territorial (SLTT) Retail Food Regulatory Agencies (U19) Clinical Trials Not Allowed |
Food and Drug Administration |
April 1st, 2024 |
Development and Maintenance of Human and Animal Food Rapid Response Teams (U2F) Clinical Trials Not Allowed |
Food and Drug Administration |
April 1st, 2024 |
Flexible Funding Model-Infrastructure Development and Maintenance for State Manufactured Food Regulatory Programs (U19) Clinical Trials Not Allowed |
Food and Drug Administration |
April 5th, 2024 |
Novel Approaches to Support Therapeutic Development in Ultra-Rare Cancers (U01) Clinical Trial Optional |
Food and Drug Administration |
June 27th, 2024 |
Continuous Ketone Monitoring for the Safe Use of Sodium-glucose Cotransporter-2 Inhibitors in Type 1 Diabetes (R01 Clinical trial Required) |
National Institutes of Health |
March 18th, 2024 |
Supporting the Use of Traditional Indigenous Foods in the Child Nutrition Programs |
Food and Nutrition Service |
|
March 31st, 2024 |
Synthesis and Biological Activity Assessment of Different Diastereomers in siRNA Drug LEQVIO (Inclisiran) (U01) Clinical Trial Not Allowed |
Food and Drug Administration |
March 31st, 2024 |
Identification of Drug-related and Formulation-Related Factors that Result in Alcohol Dose Dumping of Modified Release Oral Drug Products (U01) Clinical Trial Not Allowed |
Food and Drug Administration |
March 31st, 2024 |
Improving Predictability of Food-Drug and Drug-Drug Interaction Risks by Utilizing In Vitro Simulated Gastrointestinal Dissolution Model for High-Risk Oral Drug Products (U01) Clinical Trial Optional |
Food and Drug Administration |
March 31st, 2024 |
Evaluating the Cutaneous Pharmacokinetics of Topical Drug Products Using Pharmacokinetic Tomography (U01 Clinical Trial Required) |
Food and Drug Administration |
March 31st, 2024 |
Utilizing Real-World Data and Algorithmic Analyses to Assess Post-Market Clinical Outcomes in Patients Switching Amongst Therapeutically Equivalent Complex Generic Drug Products and Reference Listed Drugs (U01) Clinical |
Food and Drug Administration |
March 31st, 2024 |
Developing PBPK Model-Based Mechanistic IVIVCs for Long Acting Injectable Suspensions and Implants (U01) Clinical Trial Optional |
Food and Drug Administration |
March 31st, 2024 |
Integrating Machine Learning with Computational Fluid Dynamics Models of Orally Inhaled Drug Products (U01) Clinical Trials Not Allowed |
Food and Drug Administration |
November 5th, 2026 |
NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Required) |
National Institutes of Health |
November 5th, 2026 |
NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
June 10th, 2027 |
NIDDK High Risk Multi-Center Clinical Study Implementation Planning Cooperative Agreements (U34 Clinical Trial Optional) |
National Institutes of Health |
March 4th, 2024 |
Collaborations to Enhance Drug Development and Regulatory Science - Clinical Trials Optional |
Food and Drug Administration |
March 4th, 2024 |
Critical Path Public Private Partnerships Clinical Trials Optional |
Food and Drug Administration |
March 18th, 2024 |
Cooperative Agreement to Support a Human Abuse Potential Study of Botanical Kratom (U01 Clinical Trial Required) |
Food and Drug Administration |
December 28th, 2026 |
Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Basic Experimental Studies with Human Required) |
National Institutes of Health |
December 28th, 2026 |
Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
February 27th, 2024 |
Identification and Evaluation of Possible Approaches to Addressing Nitrosamine Impurities in Drugs (U01) Here and Clinical Trial Designator - Clinical Trials Not Allowed |
Food and Drug Administration |
February 27th, 2024 |
Strengthening Global Competency and Capacity in Inspectional Approaches for the Oversight of Human and Animal Pharmaceutical Products (U01) Clinical Trials Not Allowed |
Food and Drug Administration |
February 29th, 2024 |
OMHHE Educational Funding Opportunity: Expanding education on skin lightening products (U01) Clinical Trials Not Allowed |
Food and Drug Administration |
February 29th, 2024 |
FDA OMHHE Health Equity Innovation Award: Enhance Equity Funding Opportunity (U01) Clinical Trials Not Allowed |
Food and Drug Administration |
January 30th, 2026 |
NIDDK Education Program Grants (R25 Clinical Trial Not Allowed) |
National Institutes of Health |